Leukemia, lymphocytic, chronic, b-cell

Results 161 to 170 of about 40,924 (174)

Dual Role of Natural Killer Cells in Early Pregnancy: Immunopathological Implications and Therapeutic Potential in Recurrent Spontaneous Abortion and Recurrent Implantation Failure

Cell Proliferation, EarlyView.
This article elaborates on the role of NK cells in early pregnancy from multiple perspectives, including molecular mechanisms and therapeutic interventions. It also discusses how NK cell dysfunction contributes to RSA and RIF, aiming to provide insights for future research on NK cell mechanisms and clinical treatment of RSA and RIF.
Defeng Guan +5 more
wiley +1 more source

Some of the next articles are maybe not open access.

Related searches:

medicine
biology

Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia.

Blood, 1998
B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of resting lymphocytes. The identification of p27(kip1), a cyclin-dependent kinase inhibitor that contributes to cell cycle arrest and represents a link between ...
R. Vrhovac +5 more
semanticscholar +1 more source

Human medicines European public assessment report (EPAR): MabThera, rituximab, Lymphoma, Non-Hodgkin,Arthritis, Rheumatoid,Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 02/06/1998, Revision: 44, Status: Authorised

Case Medical Research, 2019

semanticscholar +1 more source

Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Lymphoma, Mantle-Cell,Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 21/10/2014, Revision: 14, Status: Authorised

Case Medical Research, 2019

semanticscholar +1 more source

Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 04/12/2016, Revision: 8, Status: Authorised

Case Medical Research, 2019

semanticscholar +1 more source

Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 22/07/2014, Revision: 8, Status: Authorised

Case Medical Research, 2019

semanticscholar +1 more source

Human medicines European public assessment report (EPAR): Zydelig, idelalisib, Lymphoma, Non-Hodgkin,Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 18/09/2014, Revision: 15, Status: Authorised

Case Medical Research, 2019

semanticscholar +1 more source

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Lymphoma, Non-Hodgkin,Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 13/07/2017, Revision: 6, Status: Authorised

Case Medical Research, 2019

semanticscholar +1 more source